BackTelomir Pharmaceuticals Overview

Telomir Pharmaceuticals Accounts Payable

Track Telomir Pharmaceuticals's accounts payable ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$0.00

Peer average

Loading

Telomir Pharmaceuticals Accounts Payable History

Loading

Telomir Pharmaceuticals vs. peers: Accounts Payable Comparison

Loading

Telomir Pharmaceuticals Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Telomir Pharmaceuticals (TELO) FAQ

Telomir Pharmaceuticals (TELO) currently reports a accounts payable of $0 as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Telomir Pharmaceuticals's accounts payable history and peer comparisons.

Telomir Pharmaceuticals's accounts payable changed from $0 to $0 (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Telomir Pharmaceuticals reported $0 in accounts payable as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Telomir Pharmaceuticals, and consider following TELO for alerts when major investors trade the stock.